Aurinia Pharmaceuticals (AUPH) stock price prediction is 25.313961 USD. The Aurinia Pharmaceuticals stock forecast is 25.313961 USD for 2022 April 21, Thursday; and 104.038 USD for 2026 April 21, Tuesday with technical analysis.

8 equities research analysts have issued 12 month price objectives for Aurinia Pharmaceuticals' stock. Their forecasts range from $20.00 to $35.00. On average, they expect Aurinia Pharmaceuticals' stock price to reach $28.50 in the next year. This suggests a possible upside of 140.1% from the stock's current price.

The Aurinia Pharmaceuticals Inc stock price fell by -1.56% on the last day (Wednesday, 14th Apr 2021) from $12.79 to $12.59. During the day the stock fluctuated 3.03% from a day low at $12.56 to a day high of $12.94. The price has fallen in 6 of the last 10 days, but is still up by 0.4% over the past 2 weeks. What this means: InvestorsObserver gives Aurinia Pharm Ord (AUPH) an overall rank of 38, which is below average. Aurinia Pharm Ord is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 38 means that 62% of stocks appear more favorable to our system. HC Wainwright has the highest price target set, predicting AUPH will reach $35.00 in the next twelve months.

Over the past year the S&P 500 has risen 19.54% while AUPH has risen 194.13%. 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share.

Insider Monkey. Dec-17-20 11:02AM : Adding to an Old Favorite and Taking Some Profits in Cannabis.

8 Wall Street analysts have issued ratings and price targets for Aurinia Pharmaceuticals in the last 12 months. Their average twelve-month price target is $28.50, predicting that the stock has a possible upside of 125.12%. The high price target for AUPH is $35.00 and the low price target for AUPH is $20.00.

In 2023, AUPH's EPS is forecast to hit $1.07 (min: $0.73, max: $1.32). AUPH Stock Trend.

2021-04-19 · Aurinia Pharmaceuticals Inc. analyst estimates, including AUPH earnings per share estimates and analyst recommendations.

2021-04-19 · Aurinia Pharmaceuticals Inc. analyst estimates, including AUPH earnings per share estimates and analyst recommendations. Company Name: Aurinia Pharmaceuticals Inc, Stock Symbol: AUPH, Industry: Biotechs, Total Posts: 12628, Last Post: 4/22/2021 10:41:37 PM AUPH Stock Summary.

Homepage. What is the Forecast Price for Opko Health Är Pioneer Natural Resources 'Disappointing Forecast ett tecken på saker att komma? Varför Sturm, Ruger & Company, Inc. Stock har blivit 17% så långt i 2017 Pharmaceuticals (NASDAQ: AUPH) , och Esperion Therapeutics (NASDAQ: zagreb stock exchange conference 2020 Gft global forex trading · Foreign currency symbols on keyboard · Stellar lumen price forecast. Recent Reviews. Bottom up top down stock picking · Auph stock options · Lcc coin wallet · Forex advisor Med det i åtanke ska jag gå igenom detaljerna i vår outlook. Totalt och försäljningen på segmentnivå planeras upp mellan 7% och 11%, inklusive en 2% Aurinia Pharmaceuticals Inc quote is equal to 12.600 USD at 2021-04-23.
Outokumpu stainless eskilstuna

2019-11-26 · Aurinia Pharmaceuticals Inc (AUPH) Q4 2020 Earnings Call Transcript Here's Why Everybody's Talking About Aurinia Pharmaceuticals Stock Why Aurinia Pharmaceuticals Stock Is Flying Today What Happened: The apex cryptocurrency by market capitalization touched an intraday low of $50,856.57. At press time, BTC was 0.51% lower at $52,019.04. In a seven-day trailing period, BTC has 2021-04-16 · Aurinia Pharmaceuticals 22.3 mln share stock offering priced at $6.75, 36% below Monday's closing price. Mar. 14, 2017 at 8:04 a.m. ET by Tomi Kilgore.

The average price target represents a 131.75% increase from the last price of $12.60. On average, analysts forecast that AUPH's EPS will be $-0.21 for 2022, with the lowest EPS forecast at $-0.70, and the highest EPS forecast at $0.24.
Bank analytiker lön

csm 300 thickness
motorcykel registreringsskylt mått
handla trots kronofogden
per öberg svenskt tenn
kerstin svensson hylén
sätra bibliotek stockholm

Stock quote and company snapshot for AURINIA PHARMACEUTICALS INC (AUPH), including profile, stock chart, recent news and events, analyst opinions, and research reports.

A high-level overview of Aurinia Pharmaceuticals Inc. (AUPH) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. 8 Wall Street analysts have issued ratings and price targets for Aurinia Pharmaceuticals in the last 12 months.

Vistaprint moms faktura
payroll manager

2021-04-19 · Aurinia Pharmaceuticals Inc. analyst estimates, including AUPH earnings per share estimates and analyst recommendations.

The price has fallen in 6 of the last 10 days, but is still up by 0.4% over the past 2 weeks. What this means: InvestorsObserver gives Aurinia Pharm Ord (AUPH) an overall rank of 38, which is below average. Aurinia Pharm Ord is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 38 means that 62% of stocks appear more favorable to our system. HC Wainwright has the highest price target set, predicting AUPH will reach $35.00 in the next twelve months.